Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Publications

Search Items: MULTIPLE MYELOMA, . hits: 62

2023

Benda, MA; Ulmer, H; Weger, R; Reimann, P; Lang, TRS; Pichler, P; Winder, T; Hartmann, B; Strassl, I; Krauth, MT; Agis, H; Sormann, S; Podar, K; Willenbacher, W; Willenbacher, E Attrition Rates in Multiple Myeloma Treatment under Real World Conditions-An Analysis from the Austrian Myeloma Registry (AMR)
CANCERS. 2023; 15(3): 962 Doi: 10.3390/cancers15030962 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

2022

Baumgart, L; Barz, M; Delbridge, C; Aftahy, AK; Janssen, IK; Jost, PJ; Ryang, YM; Meyer, B; Gempt, J Spinal Lesions as Clinical Manifestations of Plasma Cell Neoplasia
CURR ONCOL. 2022; 29(9): 6236-6244. Doi: 10.3390/curroncol29090490 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Neumeister, P; Schulz, E; Pansy, K; Szmyra, M; Deutsch, AJ Targeting the Microenvironment for Treating Multiple Myeloma.
Int J Mol Sci. 2022; 23(14): 7627 Doi: 10.3390/ijms23147627 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

2021

Strassl, I; Schreder, M; Steiner, N; Rudzki, J; Agis, H; Künz, T; Müser, N; Willenbacher, W; Petzer, A; Neumeister, P; Krauth, MT The Agony of Choice-Where to Place the Wave of BCMA-Targeted Therapies in the Multiple Myeloma Treatment Puzzle in 2022 and Beyond.
Cancers (Basel). 2021; 13(18): Doi: 10.3390/cancers13184701 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

2020

Cowan, AJ; Baldomero, H; Atsuta, Y; Mikhael, J; Aljurf, M; Seber, A; Greinix, H; Koh, M; Worel, N; Libby, EN; Pasquini, M; Galeano, S; Saber, W; Iida, M; Jaimovich, G; Rolon, JM; Kodera, Y; Benakli, M; Nosa, BG; Elhaddad, A; Szer, J; Passweg, J; Kroeger, N; Weisdorf, D; Niederwieser, D The Global State of Hematopoietic Cell Transplantation for Multiple Myeloma: An Analysis of the Worldwide Network of Blood and Marrow Transplantation Database and the Global Burden of Disease Study.
Biol Blood Marrow Transplant. 2020; 26(12):2372-2377 Doi: 10.1016/j.bbmt.2020.08.018 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

2019

Willenbacher, E; Weger, R; Bittrich, M; Einsele, H; Sormann, S; Bauer, F; Willenbacher, W ALPINA: Real World Analysis of 1st line RVd treatment in Transplant Eligible & Transplant-non-Eligible MM patients with a focus on tolerability and efficacy
CL LYMPH MYELOM LEUK. Abstract Book 17th International Myeloma Workshop. 2019; 19(10):E220-E220.-17th International Myeloma Workshop; SEP 12-15, 2019; Boston, USA. Doi: 10.1016/j.clml.2019.09.366 [Poster]
Web of Science FullText FullText_MUG

2018

Antlanger, M; Dust, T; Reiter, T; Böhm, A; Lamm, WW; Gornicec, M; Willenbacher, E; Nachbaur, D; Weger, R; Rabitsch, W; Rasoul-Rockenschaub, S; Worel, N; Lechner, D; Greinix, H; Keil, F; Gisslinger, H; Agis, H; Krauth, MT Impact of renal impairment on outcomes after autologous stem cell transplantation in multiple myeloma: a multi-center, retrospective cohort study.
BMC CANCER. 2018; 18(1): 1008-1008. Doi: 10.1186/s12885-018-4926-0 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Rinnerthaler, G; Gampenrieder, SP; Petzer, A; Burgstaller, S; Fuchs, D; Rossmann, D; Balic, M; Egle, D; Rumpold, H; Singer, CF; Bartsch, R; Petru, E; Melchardt, T; Ulmer, H; Mlineritsch, B; Greil, R Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial).
BMC CANCER. 2018; 18(1): 1074-1074. Doi: 10.1186/s12885-018-4979-0 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Vlot, MC; den Heijer, M; de Jongh, RT; Vervloet, MG; Lems, WF; de Jonge, R; Obermayer-Pietsch, B; Heijboer, AC Clinical utility of bone markers in various diseases.
Bone. 2018; 114(7):215-225 Doi: 10.1016/j.bone.2018.06.011
Web of Science PubMed FullText FullText_MUG

2017

Fung, P; Bedogni, G; Bedogni, A; Petrie, A; Porter, S; Campisi, G; Bagan, J; Fusco, V; Saia, G; Acham, S; Musto, P; Petrucci, MT; Diz, P; Colella, G; Mignogna, MD; Pentenero, M; Arduino, P; Lodi, G; Maiorana, C; Manfredi, M; Hallberg, P; Wadelius, M; Takaoka, K; Leung, YY; Bonacina, R; Schiødt, M; Lakatos, P; Taylor, T; De Riu, G; Favini, G; Rogers, SN; Pirmohamed, M; Nicoletti, P; GENVABO Consortium; Fedele, S Time to onset of bisphosphonate-related osteonecrosis of the jaws: a multicentre retrospective cohort study.
Oral Dis. 2017; 23(4):477-483 Doi: 10.1111/odi.12632 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Robier, C; Piribauer, M; Beham-Schmid, C; Aubell, K; Neubauer, M IgD-lambda myeloma with extensive free light-chain excretion: a diagnostic pitfall in the identification of monoclonal gammopathies
CLIN CHEM LAB MED. 2017; 55(7): E137-E139. Doi: 10.1515/cclm-2016-0653
Web of Science PubMed FullText FullText_MUG

Sezer, O; Beksac, M; Hajek, R; Sucak, G; Cagirgan, S; Linkesch, W; Meltem Akay, O; Gülbas, Z; Nahi, H; Plesner, T; Snowden, JA; Timurağaoğlu, A; Dechow, T; Lang, A; Tuğlular, T; Drach, J; Armbrecht, G; Potamianou, A; Couturier, C; Olie, RA; Feys, C; Allietta, N; Terpos, E Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study.
Br J Haematol. 2017; 178(1):61-71 Doi: 10.1111/bjh.14637 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Worel, N; Fritsch, G; Agis, H; Böhm, A; Engelich, G; Leitner, GC; Geissler, K; Gleixner, K; Kalhs, P; Buxhofer-Ausch, V; Keil, F; Kopetzky, G; Mayr, V; Rabitsch, W; Reisner, R; Rosskopf, K; Ruckser, R; Zoghlami, C; Zojer, N; Greinix, HT Plerixafor as preemptive strategy results in high success rates in autologous stem cell mobilization failure.
J Clin Apher. 2017; 32(4):224-234 Doi: 10.1002/jca.21496
Web of Science PubMed FullText FullText_MUG

2016

Juric, MK; Shevtsov, M; Mozes, P; Ogonek, J; Crossland, RE; Dickinson, AM; Greinix, HT; Holler, E; Weissinger, EM; Multhoff, G B-Cell-Based and Soluble Biomarkers in Body Liquids for Predicting Acute/Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Front Immunol. 2016; 7(3):660-660 Doi: 10.3389/fimmu.2016.00660 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Langsteger, W; Rezaee, A; Loidl, W; Geinitz, HS; Fitz, F; Steinmair, M; Broinger, G; Pallwien-Prettner, L; Beheshti, M; Imamovic, L; Beheshti, M; Rendl, G; Hackl, D; Tsybrovsky, O; Steinmair, M; Emmanuel, K; Moinfar, F; Pirich, C; Langsteger, W; Bytyqi, A; Karanikas, G; Mayerhöfer, M; Koperek, O; Niederle, B; Hartenbach, M; Beyer, T; Herrmann, K; Czernin, J; Rausch, I; Rust, P; DiFranco, MD; Lassen, M; Stadlbauer, A; Mayerhöfer, ME; Hartenbach, M; Hacker, M; Beyer, T; Binzel, K; Magnussen, R; Wei, W; Knopp, MU; Flanigan, DC; Kaeding, C; Knopp, MV; Leisser, A; Nejabat, M; Hartenbach, M; Kramer, G; Krainer, M; Hacker, M; Haug, A; Lehnert, W; Schmidt, K; Kimiaei, S; Bronzel, M; Kluge, A; Wright, CL; Binzel, K; Zhang, J; Wuthrick, E; Maniawski, P; Knopp, MV; Blaickner, M; Rados, E; Huber, A; Dulovits, M; Kulkarni, H; Wiessalla, S; Schuchardt, C; Baum, RP; Knäusl, B; Georg, D; Bauer, M; Wulkersdorfer, B; Wadsak, W; Philippe, C; Haslacher, H; Zeitlinger, M; Langer, O; Bauer, M; Feldmann, M; Karch, R; Wadsak, W; Zeitlinger, M; Koepp, MJ; Asselin, MC; Pataraia, E; Langer, O; Zeilinger, M; Philippe, C; Dumanic, M; Pichler, F; Pilz, J; Hacker, M; Wadsak, W; Mitterhauser, M; Nics, L; Steiner, B; Hacker, M; Mitterhauser, M; Wadsak, W; Traxl, A; Wanek, T; Kryeziu, K; Mairinger, S; Stanek, J; Berger, W; Kuntner, C; Langer, O; Mairinger, S; Wanek, T; Traxl, A; Krohn, M; Stanek, J; Filip, T; Sauberer, M; Kuntner, C; Pahnke, J; Langer, O; Svatunek, D; Denk, C; Wilkovitsch, M; Wanek, T; Filip, T; Kuntner-Hannes, C; Fröhlich, J; Mikula, H; Denk, C; Svatunek, D; Wanek, T; Mairinger, S; Stanek, J; Filip, T; Fröhlich, J; Mikula, H; Kuntner-Hannes, C; Balber, T; Singer, J; Fazekas, J; Rami-Mark, C; Berroterán-Infante, N; Jensen-Jarolim, E; Wadsak, W; Hacker, M; Viernstein, H; Mitterhauser, M; Denk, C; Svatunek, D; Sohr, B; Mikula, H; Fröhlich, J; Wanek, T; Kuntner-Hannes, C; Filip, T; Pfaff, S; Philippe, C; Mitterhauser, M; Hartenbach, M; Hacker, M; Wadsak, W; Wanek, T; Halilbasic, E; Visentin, M; Mairinger, S; Stieger, B; Kuntner, C; Trauner, M; Langer, O; Lam, P; Aistleitner, M; Eichinger, R; Artner, C; Eidherr, H; Vraka, C; Haug, A; Mitterhauser, M; Nics, L; Hartenbach, M; Hacker, M; Wadsak, W; Kvaternik, H; Müller, R; Hausberger, D; Zink, C; Aigner, RM; Cossío, U; Asensio, M; Montes, A; Akhtar, S; Te Welscher, Y; van Nostrum, R; Gómez-Vallejo, V; Llop, J; VandeVyver, F; Barclay, T; Lippens, N; Troch, M; Hehenwarter, L; Egger, B; Holzmannhofer, J; Rodrigues-Radischat, M; Pirich, C; Pötsch, N; Rausch, I; Wilhelm, D; Weber, M; Furtner, J; Karanikas, G; Wöhrer, A; Mitterhauser, M; Hacker, M; Traub-Weidinger, T; Cassou-Mounat, T; Balogova, S; Nataf, V; Calzada, M; Huchet, V; Kerrou, K; Devaux, JY; Mohty, M; Garderet, L; Talbot, JN; Stanzel, S; Pregartner, G; Schwarz, T; Bjelic-Radisic, V; Liegl-Atzwanger, B; Aigner, R; Stanzel, S; Quehenberger, F; Aigner, RM; Marković, AK; Janković, M; Jerković, VM; Paskaš, M; Pupić, G; Džodić, R; Popović, D; Fornito, MC; Familiari, D; Koranda, P; Polzerová, H; Metelková, I; Henzlová, L; Formánek, R; Buriánková, E; Kamínek, M; Thomson, WH; Lewis, C; Thomson, WH; O'Brien, J; James, G; Notghi, A; Huber, H; Stelzmüller, I; Wunn, R; Mandl, M; Fellner, F; Lamprecht, B; Gabriel, M; Fornito, MC; Leonardi, G; Thomson, WH; O'Brien, J; James, G; Hudzietzová, J; Sabol, J; Fülöp, M 32nd International Austrian Winter Symposium : Zell am See, the Netherlands. 20-23 January 2016.
EJNMMI Res. 2016; 6(Suppl 1):32-32. Doi: 10.1186/s13550-016-0168-9 [Keynote lecture] [OPEN ACCESS]
PubMed FullText FullText_MUG

Losada, A; Muñoz-Alonso, MJ; García, C; Sánchez-Murcia, PA; Martínez-Leal, JF; Domínguez, JM; Lillo, MP; Gago, F; Galmarini, CM Translation Elongation Factor eEF1A2 is a Novel Anticancer Target for the Marine Natural Product Plitidepsin.
Sci Rep. 2016; 6(6):35100-35100 Doi: 10.1038/srep35100 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Rugani, P; Walter, C; Kirnbauer, B; Acham, S; Begus-Nahrman, Y; Jakse, N Prevalence of Medication-Related Osteonecrosis of the Jaw in Patients with Breast Cancer, Prostate Cancer, and Multiple Myeloma.
Dent J (Basel). 2016; 4(4): Doi: 10.3390/dj4040032 [OPEN ACCESS]
PubMed FullText FullText_MUG

Wenzl, K; Hofer, S; Troppan, K; Lassnig, M; Steinbauer, E; Wiltgen, M; Zulus, B; Renner, W; Beham-Schmid, C; Neumeister, P; Deutsch, A Higher incidence of the SNP Met 788 Ile in the coding region of A20 in diffuse large B cell lymphomas.
Tumour Biol. 2016; 37(4):4785-4789 Doi: 10.1007/s13277-015-4322-1 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Wibmer, C; Amrein, K; Fahrleitner-Pammer, A; Gilg, MM; Berghold, A; Hutterer, GC; Maurer-Ertl, W; Gerger, A; Leithner, A; Pichler, M; Szkandera, J Serum sclerostin levels in renal cell carcinoma patients with bone metastases.
Sci Rep. 2016; 6(4):33551-33551 Doi: 10.1038/srep33551 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

2015

Iacobelli, S; de Wreede, LC; Schönland, S; Björkstrand, B; Hegenbart, U; Gruber, A; Greinix, H; Volin, L; Narni, F; Carella, AM; Beksac, M; Bosi, A; Milone, G; Corradini, P; Friberg, K; van Biezen, A; Goldschmidt, H; de Witte, T; Morris, C; Niederwieser, D; Garderet, L; Kröger, N; Gahrton, G; EBMT CMWP, Plasma Cell Disorders Subcommittee Impact of CR before and after allogeneic and autologous transplantation in multiple myeloma: results from the EBMT NMAM2000 prospective trial.
Bone Marrow Transplant. 2015; 50(4):505-510 Doi: 10.1038/bmt.2014.310 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Lamm, W; Wohlfarth, P; Bojic, M; Schörgenhofer, C; Drach, J; Gisslinger, H; Worel, N; Schiefer, A; Schulenburg, A; Agis, H; Kalhs, P; Greinix, HT; Schellongowski, P; Rabitsch, W Outcome in Multiple Myeloma Patients Eligible for Stem Cell Transplantation: A Single-Center Experience.
Oncology. 2015; 89(4): 196-204. Doi: 10.1159/000437055
Web of Science PubMed FullText FullText_MUG

Troppan, K; Hofer, S; Wenzl, K; Lassnig, M; Pursche, B; Steinbauer, E; Wiltgen, M; Zulus, B; Renner, W; Beham-Schmid, C; Deutsch, A; Neumeister, P Frequent down regulation of the tumor suppressor gene a20 in multiple myeloma.
PLoS One. 2015; 10(4):e0123922-e0123922 Doi: 10.1371/journal.pone.0123922 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

2014

Ludwig, H; Kasparu, H; Leitgeb, C; Rauch, E; Linkesch, W; Zojer, N; Greil, R; Seebacher, A; Pour, L; Weißmann, A; Adam, Z Bendamustine-bortezomib-dexamethasone is an active and well-tolerated regimen in patients with relapsed or refractory multiple myeloma.
Blood. 2014; 123(7):985-991 Doi: 10.1182/blood-2013-08-521468 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Riedl, J; Posch, F; Königsbrügge, O; Lötsch, F; Reitter, EM; Eigenbauer, E; Marosi, C; Schwarzinger, I; Zielinski, C; Pabinger, I; Ay, C Red cell distribution width and other red blood cell parameters in patients with cancer: association with risk of venous thromboembolism and mortality.
PLoS One. 2014; 9(10):e111440-e111440 Doi: 10.1371/journal.pone.0111440 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Steinbrunn, T; Stuhmer, T; Gattenlohner, S; Rosenwald, A; Mottok, A; Unzicker, C; Einsele, H; Chatterjee, M; Bargou, RC Mutated RAS and constitutively activated Akt delineate distinct oncogenic pathways, which independently contribute to multiple myeloma cell survival.
Blood. 2011; 117(6):1998-2004 Doi: 10.1182/blood-2010-05-284422 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Worel, N; Rosskopf, K; Neumeister, P; Kasparu, H; Nachbaur, D; Russ, G; Namberger, K; Witt, V; Schloegl, E; Zojer, N; Linkesch, W; Kalhs, P; Greinix, HT Plerixafor and granulocyte-colony-stimulating factor (G-CSF) in patients with lymphoma and multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy for autologous hematopoietic stem cell mobilization: the Austrian experience on a named patient program.
Transfusion. 2011; 51(5):968-975 Doi: 10.1111/j.1537-2995.2010.02896.x
Web of Science PubMed FullText FullText_MUG

2010

Rugani, P; Acham, S; Truschnegg, A; Obermayer-Pietsch, B; Jakse, N Bisphosphonate-associated osteonecrosis of the jaws: surgical treatment with ErCrYSGG-laser. Case report.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010; 110(6):e1-e6 Doi: 10.1016/j.tripleo.2010.08.013 (- Case Report)
Web of Science PubMed FullText FullText_MUG

2009

Huber, JM; Tagwerker, A; Heininger, D; Mayer, G; Rosenkranz, AR; Eller, K The proteasome inhibitor bortezomib aggravates renal ischemia-reperfusion injury.
Am J Physiol Renal Physiol. 2009; 297(2):F451-F460 Doi: 10.1152/ajprenal.90576.2008 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

2008

Bink, K; Haralambieva, E; Kremer, M; Ott, G; Beham-Schmid, C; de Leval, L; Peh, SC; Laeng, HR; Jütting, U; Hutzler, P; Quintanilla-Martinez, L; Fend, F Primary extramedullary plasmacytoma: similarities with and differences from multiple myeloma revealed by interphase cytogenetics.
Haematologica. 2008; 93(4): 623-626. Doi: 10.3324/haematol.12005 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Leithner, A; Radl, R; Gruber, G; Hochegger, M; Leithner, K; Welkerling, H; Rehak, P; Windhager, R Predictive value of seven preoperative prognostic scoring systems for spinal metastases.
Eur Spine J. 2008; 17(11): 1488-1495. Doi: 10.1007/s00586-008-0763-1 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

Sarkozi, R; Perco, P; Hochegger, K; Enrich, J; Wiesinger, M; Pirklbauer, M; Eder, S; Rudnicki, M; Rosenkranz, AR; Mayer, B; Mayer, G; Schramek, H Bortezomib-induced survival signals and genes in human proximal tubular cells.
J Pharmacol Exp Ther. 2008; 327(3):645-656 Doi: 10.1124/jpet.108.142604 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Zollinger, A; Stuhmer, T; Chatterjee, M; Gattenlohner, S; Haralambieva, E; Muller-Hermelink, HK; Andrulis, M; Greiner, A; Wesemeier, C; Rath, JC; Einsele, H; Bargou, RC Combined functional and molecular analysis of tumor cell signaling defines 2 distinct myeloma subgroups: Akt-dependent and Akt-independent multiple myeloma.
Blood. 2008; 112(8):3403-3411 Doi: 10.1182/blood-2007-11-119362 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

2006

Markert, E; Gruber-Moesenbacher, U; Porubsky, C; Popper, HH Lung osteoma--a new benign lung lesion.
Virchows Arch. 2006; 449(1):117-120 Doi: 10.1007/s00428-006-0205-6 (- Case Report)
Web of Science PubMed FullText FullText_MUG

2005

Ludwig, H; Spicka, I; Klener, P; Greil, R; Adam, Z; Gisslinger, H; Tarkovács, G; Linkesch, W; Maniatis, A; Morant, R; Drach, J; Kuhn, I; Schuster, J; Hinke, A Continuous prednisolone versus conventional prednisolone with VMCP-interferon-alpha2b as first-line chemotherapy in elderly patients with multiple myeloma.
BRIT J HAEMATOL. 2005; 131(3): 329-337. Doi: 10.1111/j.1365-2141.2005.05779.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

2004

Rabitsch, W; Prinz, E; Ackermann, J; Wöhrer, S; Kaufmann, H; Seidl, S; Keil, F; Kalhs, P; Greinix, H; Gisslinger, H; Leitner, G; Drach, J Long-term follow up of patients with multiple myeloma after high-dose chemotherapy and allogeneic stem cell transplantation.
Eur J Haematol. 2004; 72(1): 26-31. Doi: 10.1046/j.0902-4441.2004.00178.x
Web of Science PubMed FullText FullText_MUG

2003

Filipits, M; Pohl, G; Stranzl, T; Kaufmann, H; Ackermann, J; Gisslinger, H; Greinix, H; Chott, A; Drach, J Low p27Kip1 expression is an independent adverse prognostic factor in patients with multiple myeloma.
Clin Cancer Res. 2003; 9(2):820-826
Web of Science PubMed

Kaufmann, H; Ackermann, J; Greinix, H; Nösslinger, T; Gisslinger, H; Keck, A; Ludwig, H; Worel, N; Kalhs, P; Zielinski, C; Drach, J Beneficial effect of high-dose chemotherapy in multiple myeloma patients with unfavorable prognostic features.
Ann Oncol. 2003; 14(11):1667-1672 Doi: 10.1093/annonc/mdg454 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

2002

Auner, HW; Sill, H; Mulabecirovic, A; Linkesch, W; Krause, R Infectious complications after autologous hematopoietic stem cell transplantation: comparison of patients with acute myeloid leukemia, malignant lymphoma, and multiple myeloma.
ANN HEMATOL 2002 81: 374-377. Doi: 10.1007/s00277-002-0484-1
Web of Science PubMed FullText FullText_MUG Google Scholar

Frohn, C; Höppner, M; Schlenke, P; Kirchner, H; Koritke, P; Luhm, J Anti-myeloma activity of natural killer lymphocytes.
Br J Haematol. 2002; 119(3):660-664 Doi: 10.1046/j.1365-2141.2002.03879.x
Web of Science PubMed FullText FullText_MUG

Mitterbauer, M; Kalhs, P; Keil, F; Prinz, E; Moser, K; Mannhalter, C; Mitterbauer, G; Brugger, S; Gisslinger, H; Lechner, K; Greinix, HT Continuous complete clinical and molecular remission in two patients with refractory lymphoid malignancies after autografting followed by allogeneic stem cell transplantation with reduced intensity conditioning.
Br J Haematol. 2002; 118(1):132-135 Doi: 10.1046/j.1365-2141.2002.03562.x (- Case Report)
Web of Science PubMed FullText FullText_MUG

2001

Worel, N; Greinix, H; Ackermann, J; Kaufmann, H; Urbauer, E; Höcker, P; Gisslinger, H; Lechner, K; Kalhs, P; Drach, J Deletion of chromosome 13q14 detected by fluorescence in situ hybridization has prognostic impact on survival after high-dose therapy in patients with multiple myeloma.
Ann Hematol. 2001; 80(6):345-348 Doi: 10.1007/s002770100296
Web of Science PubMed FullText FullText_MUG

2000

Tinhofer, I; Marschitz, I; Henn, T; Egle, A; Greil, R Expression of functional interleukin-15 receptor and autocrine production of interleukin-15 as mechanisms of tumor propagation in multiple myeloma.
Blood. 2000; 95(2):610-618 Doi: 10.1182/blood.V95.2.610 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

1999

Konig, A; Wennemuth, G; Soyer, HP; Hoffmann, R; Happle, R; Krause, W Vulvar amyloidosis mimicking giant condylomata acuminata in a patient with multiple myeloma.
EUROPEAN J DERMATOLOGY 1999 9: 29-31. (- Case Report) [OPEN ACCESS]
Web of Science PubMed Google Scholar

Reiter, E; Kalhs, P; Keil, F; Rabitsch, W; Gisslinger, H; Mayer, G; Worel, N; Lechner, K; Greinix, HT Effect of high-dose melphalan and peripheral blood stem cell transplantation on renal function in patients with multiple myeloma and renal insufficiency: a case report and review of the literature.
Ann Hematol. 1999; 78(4):189-191 Doi: 10.1007/s002770050499 (- Case Report)
Web of Science PubMed FullText FullText_MUG

1998

Bíró, L; Domján, G; Falus, A; Jakab, L; Cseh, K; Kalabay, L; Tarkovács, G; Tresch, J; Malle, E; Kramer, J; Prohászka, Z; Jákó, J; Füst, G; Császár, A Cytokine regulation of the acute-phase protein levels in multiple myeloma.
Eur J Clin Invest. 1998; 28(8):679-686 Doi: 10.1046%2Fj.1365-2362.1998.00333.x
Web of Science PubMed FullText FullText_MUG Google Scholar

1997

Egle, A; Villunger, A; Marschitz, I; Kos, M; Hittmair, A; Lukas, P; Grünewald, K; Greil, R Expression of Apo-1/Fas (CD95), Bcl-2, Bax and Bcl-x in myeloma cell lines: relationship between responsiveness to anti-Fas mab and p53 functional status.
Br J Haematol. 1997; 97(2): 418-428. Doi: 10.1046/j.1365-2141.1997.382680.x
Web of Science PubMed FullText FullText_MUG

1996

Osterborg, A; Boogaerts, MA; Cimino, R; Essers, U; Holowiecki, J; Juliusson, G; Jäger, G; Najman, A; Peest, D Recombinant human erythropoietin in transfusion-dependent anemic patients with multiple myeloma and non-Hodgkin's lymphoma--a randomized multicenter study. The European Study Group of Erythropoietin (Epoetin Beta) Treatment in Multiple Myeloma and Non-Hodgkin's Lymphoma.
Blood. 1996; 87(7):2675-2682 Doi: 10.1182/blood.V87.7.2675.bloodjournal8772675 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Show the next 50 results of search

↑ Top of page / Navigation